All In Biotech

Free tool

FAERS Monitor: Absorica

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021951 or its brand name (Absorica, Isotretinoin). Reports on generic versions are filed under their own applications.

Reports

18,655

Serious

9,780

52% of reports

Hospitalization

1,464

Death reported

453

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • depression1,247
  • pregnancy1,042
  • exposure during pregnancy1,034
  • abortion induced805
  • product dose omission issue689
  • headache680
  • adverse drug reaction673
  • dry skin672
  • arthralgia658
  • drug ineffective604
  • suicidal ideation603
  • mood altered534
  • anxiety454
  • off label use381
  • lip dry367

Reports by year received

View as table
YearReports
2004124
2005209
2006355
2007491
2008766
2009503
2010492
2011276
2012383
2013357
2014345
2015512
2016769
2017537
2018616
2019596
2020864
20211,075
20221,580
20231,738
20242,348
20252,353
20261,366

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,504 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abortion inducedSignal805105.398.176,003
pregnancySignal1,04261.858.259,129
lip drySignal36747.442.815,970
mood alteredSignal53422.520.710,747
exposure during pregnancySignal1,03419.118.017,431
adverse drug reactionSignal6738.57.94,435
suicidal ideationSignal6037.56.93,365
depressionSignal1,2476.25.95,472
dry skinSignal6725.75.32,603
product dose omission issueSignal6892.62.5712
anxiety4541.81.6163
arthralgia6581.81.7231
headache6801.21.128
drug ineffective6040.50.5291
off label use3810.50.4210

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.